Meanwhile, those who don’t have insurance can continue to download the Lilly Insulin Value Program savings card from InsulinAffordability.com in order to receive Lilly insulins for the same price.

Since the start of 2020, Eli Lilly’s (NYSE: LLY) stock price chart has been straight up and to the right, up 491.86% and ...

(Reuters) - Eli Lilly said on Thursday it will invest $3 billion to expand the manufacturing plant it bought in Pleasant ...

Novo Nordisk's Ozempic will become the first and only GLP-1 drug to be shown to reduce progression of kidney disease in ...

Two years ago, Eli Lilly started working with Dexcom to integrate continuous glucose monitoring (CGM) into its insulin delivery devices, and it has now firmed up the alliance. Lilly has taken a ...

The school district and other health plans—not Lilly—negotiate the terms of their rebate arrangements, including whether to pass those rebates on to people who take insulin. In the only three ...

The new investment in the factory, which it acquired from Nexus Pharmaceuticals, will help boost production of Lilly's powerful weight-loss drug Zepbound as well as its diabetes treatments and ...

MADISON, Wisconsin: Eli Lilly is doubling down on manufacturing investments, announcing a US$3 billion expansion of its Wisconsin facility to meet growing demand for its blockbuster diabetes and ...

Lilly makes tirzepatide, which is approved for type 2 diabetes under the name Mounjaro and for weight control under the name Zepbound (though doctors have also prescribed Mounjaro for patients ...

The US Food and Drug Administration has approved versions of tirzepatide and semaglutide to treat both type 2 diabetes and obesity. Eli Lilly manufactures tirzepatide under the brand name Mounjaro ...